Table 1. Demographic and baseline clinical features of the three study groups.
| Characteristics | Albendazol(N = 30) | Ivermectin-I(N = 31) | Ivermectin –II(N = 29) | P-value |
| Male: female | 21∶9 | 21∶10 | 19∶10 | 0.934 |
| Median (range) age, yr | 54 (23–81) | 51 (29–77) | 52 (25–78) | 0.273 |
| Median (range) weight, kg | 59 (37–80) | 57 (37–85) | 59 (44–73) | 0.75 |
| Concomitant illnesses, n (%) | 0.607 | |||
| - None | 1 | 0 | 0 | |
| - Diabetes mellitus | 8 | 6 | 5 | |
| - NS/SLE | 4 | 5 | 4 | |
| - AIDS/HIV infection | 3 | 2 | 5 | |
| - Hematological malignancy | 2 | 3 | 4 | |
| - Solid tumor | 3 | 1 | 6 | |
| - Rheumatologic diseases | 2 | 1 | 1 | |
| - Chronic kidney disease | 3 | 2 | 2 | |
| - Alcohol drinker | 3 | 1 | 1 | |
| - Others | 6 | 12 | 4 | |
| Immunosuppressive drug, n (%) | 10 (33.3) | 11(35.5) | 11 (37.9) | 0.934 |
| Concomitant parasitoses* | 0.380 | |||
| - Hookworm infection | 2 | 1 | 0 | |
| - Opisthorchiasis | 2 | 1 | 2 | |
| - Enterobious infection | 0 | 1 | 0 | |
| - Entamoeba histolytica infection | 0 | 1 | 0 | |
| - Isospora belli infection | 0 | 0 | 1 |
*Diagnosis obtained by ova or cyst found from fecal examination.